Nicolas Iragorri1, Glen Hazlewood1,2, Braden Manns1,2,3, Vishva Danthurebandara1, Eldon Spackman1. 1. Department of Community Health Sciences, University of Calgary, Calgary. 2. Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary. 3. Strategic Clinical Networks, Alberta Health Services, Edmonton, Alberta, Canada.
Abstract
OBJECTIVE: To systematically review the accuracy and characteristics of different questionnaire-based PsA screening tools. METHODS: A systematic review of MEDLINE, Excerpta Medical Database, Cochrane Central Register of Controlled Trials and Web of Science was conducted to identify studies that evaluated the accuracy of self-administered PsA screening tools for patients with psoriasis. A bivariate meta-analysis was used to pool screening tool-specific accuracy estimates (sensitivity and specificity). Heterogeneity of the diagnostic odds ratio was evaluated through meta-regression. All full-text records were assessed for risk of bias with the QUADAS 2 tool. RESULTS: A total of 2280 references were identified and 130 records were assessed for full-text review, of which 42 were included for synthesis. Of these, 27 were included in quantitative syntheses. Of the records, 37% had an overall low risk of bias. Fourteen different screening tools and 104 separate accuracy estimates were identified. Pooled sensitivity and specificity estimates were calculated for the Psoriatic Arthritis Screening and Evaluation (cut-off = 44), Psoriatic Arthritis Screening and Evaluation (47), Toronto Psoriatic Arthritis Screening (8), Psoriasis Epidemiology Screening Tool (3) and Early Psoriatic Arthritis Screening Questionnaire (3). The Early Psoriatic Arthritis Screening Questionnaire reported the highest sensitivity and specificity (0.85 each). The I2 for the diagnostic odds ratios varied between 76 and 90.1%. Meta-regressions were conducted, in which the age, risk of bias for patient selection and the screening tool accounted for some of the observed heterogeneity. CONCLUSIONS: Questionnaire-based tools have moderate accuracy to identify PsA among psoriasis patients. The Early Psoriatic Arthritis Screening Questionnaire appears to have slightly better accuracy compared with the Toronto Psoriatic Arthritis Screening, Psoriasis Epidemiology Screening Tool and Psoriatic Arthritis Screening and Evaluation. An economic evaluation could model the uncertainty and estimate the cost-effectiveness of PsA screening programs that use different tools.
OBJECTIVE: To systematically review the accuracy and characteristics of different questionnaire-based PsA screening tools. METHODS: A systematic review of MEDLINE, Excerpta Medical Database, Cochrane Central Register of Controlled Trials and Web of Science was conducted to identify studies that evaluated the accuracy of self-administered PsA screening tools for patients with psoriasis. A bivariate meta-analysis was used to pool screening tool-specific accuracy estimates (sensitivity and specificity). Heterogeneity of the diagnostic odds ratio was evaluated through meta-regression. All full-text records were assessed for risk of bias with the QUADAS 2 tool. RESULTS: A total of 2280 references were identified and 130 records were assessed for full-text review, of which 42 were included for synthesis. Of these, 27 were included in quantitative syntheses. Of the records, 37% had an overall low risk of bias. Fourteen different screening tools and 104 separate accuracy estimates were identified. Pooled sensitivity and specificity estimates were calculated for the Psoriatic Arthritis Screening and Evaluation (cut-off = 44), Psoriatic Arthritis Screening and Evaluation (47), Toronto Psoriatic Arthritis Screening (8), Psoriasis Epidemiology Screening Tool (3) and Early Psoriatic Arthritis Screening Questionnaire (3). The Early Psoriatic Arthritis Screening Questionnaire reported the highest sensitivity and specificity (0.85 each). The I2 for the diagnostic odds ratios varied between 76 and 90.1%. Meta-regressions were conducted, in which the age, risk of bias for patient selection and the screening tool accounted for some of the observed heterogeneity. CONCLUSIONS: Questionnaire-based tools have moderate accuracy to identify PsA among psoriasispatients. The Early Psoriatic Arthritis Screening Questionnaire appears to have slightly better accuracy compared with the Toronto Psoriatic Arthritis Screening, Psoriasis Epidemiology Screening Tool and Psoriatic Arthritis Screening and Evaluation. An economic evaluation could model the uncertainty and estimate the cost-effectiveness of PsA screening programs that use different tools.
Authors: Noemi Busquets-Pérez; Helena Marzo-Ortega; Dennis Mcgonagle; Robin Waxman; Philip Helliwell Journal: Rheumatology (Oxford) Date: 2014-11-03 Impact factor: 7.580
Authors: L C Coates; T Aslam; F Al Balushi; A D Burden; Esther Burden-Teh; E Burden-The; A R Caperon; R Cerio; C Chattopadhyay; H Chinoy; M J D Goodfield; L Kay; S Kelly; B W Kirkham; C R Lovell; H Marzo-Ortega; N McHugh; R Murphy; N J Reynolds; C H Smith; E J C Stewart; R B Warren; R Waxman; H E Wilson; P S Helliwell Journal: Br J Dermatol Date: 2013-04 Impact factor: 9.302
Authors: Stefano Piaserico; Paolo Gisondi; Paolo Amerio; Giuseppe Amoruso; Anna Campanati; Andrea Conti; Clara De Simone; Giulio Gualdi; Claudio Guarneri; Anna Mazzotta; Maria L Musumeci; Damiano Abeni Journal: Acta Derm Venereol Date: 2016-08-23 Impact factor: 4.437
Authors: Leandro G Ferreyra Garrott; Enrique R Soriano; Javier E Rosa; David A Navarta; Carla Saucedo; Marina Scolnik; Zaida Bedran; Mirtha Sabelli; Maria V García; Carolina Anselmi; Ricardo Galimberti; Luis J Catoggio; M Elaine Husni; Abrar A Qureshi Journal: Rheumatology (Oxford) Date: 2012-11-21 Impact factor: 7.580
Authors: Marloes E van Muijen; Tamara W van Hal; Hans M M Groenewoud; Juul M P A van den Reek; Elke M G J de Jong Journal: Psoriasis (Auckl) Date: 2020-10-05
Authors: Sophie Belman; Jessica A Walsh; Courtney Carroll; Michael Milliken; Benjamin Haaland; Kristina Callis Duffin; Gerald G Krueger; Bing-Jian Feng Journal: J Rheumatol Date: 2021-04-15 Impact factor: 5.346
Authors: Paras Karmacharya; Kerry Wright; Sara J Achenbach; Delamo Bekele; Cynthia S Crowson; Alexis Ogdie; Alí Duarte-García; Floranne C Ernste; Megha M Tollefson; John M Davis Journal: J Rheumatol Date: 2021-02-15 Impact factor: 5.346
Authors: Florian Tran; Jan Henrik Schirmer; Ilka Ratjen; Wolfgang Lieb; Philip Helliwell; Johan Burisch; Juliane Schulz; Florian Schrinner; Charlot Jaeckel; Ulf Müller-Ladner; Stefan Schreiber; Bimba F Hoyer Journal: Front Immunol Date: 2021-03-18 Impact factor: 7.561